|
|
|
|
LEADER |
05277nam a22005415i 4500 |
001 |
978-0-387-74290-8 |
003 |
DE-He213 |
005 |
20210615184145.0 |
007 |
cr nn 008mamaa |
008 |
100301s2008 xxu| s |||| 0|eng d |
020 |
|
|
|a 9780387742908
|9 978-0-387-74290-8
|
024 |
7 |
|
|a 10.1007/978-0-387-74290-8
|2 doi
|
050 |
|
4 |
|a RC466.8
|
072 |
|
7 |
|a MMJ
|2 bicssc
|
072 |
|
7 |
|a PSY007000
|2 bisacsh
|
072 |
|
7 |
|a MKM
|2 thema
|
082 |
0 |
4 |
|a 616.89
|2 23
|
245 |
1 |
0 |
|a Anxiety and Substance Use Disorders
|h [electronic resource] :
|b The Vicious Cycle of Comorbidity /
|c edited by Sherry H. Stewart, Patricia Conrod.
|
250 |
|
|
|a 1st ed. 2008.
|
264 |
|
1 |
|a New York, NY :
|b Springer US :
|b Imprint: Springer,
|c 2008.
|
300 |
|
|
|a XXI, 276 p.
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
347 |
|
|
|a text file
|b PDF
|2 rda
|
490 |
1 |
|
|a Series in Anxiety and Related Disorders
|
505 |
0 |
|
|a Theoretical Issues -- Epidemiological Perspectives on Co-Occurring Anxiety Disorder and Substance Use Disorder -- The Neurobiology of Anxiety: Potential for Co-Morbidity of Anxiety and Substance Use Disorders -- Research Findings -- Posttraumatic Stress Disorder and Substance Use Disorder: Neuroimaging, Neuroendocrine, and Psychophysiological Findings -- Co-Morbidity of Social Phobia and Alcohol Use Disorders: A Review of Psychopathology Research Findings -- Panic Spectrum Disorders and Substance Use -- Treatment Strategies -- Treatment of Co-Morbid Obsessive-Compulsive Disorder and Substance Use Disorders -- Treatment for Co-Morbid Posttraumatic Stress Disorder and Substance Use Disorders -- Treatment of Co-Occurring Alcoholism and Social Anxiety Disorder -- Treating Co-Morbid Panic Disorder and Substance Use Disorder -- Cognitive-Behavioral Treatment of Co-morbid Panic Psychopathology and Tobacco Use and Dependence -- Personality-based Approaches to Treatment of Co-morbid Anxiety and Substance Use Disorder -- Medical Management of Co-Morbid Anxiety and Substance Use Disorder -- Integration And Conclusions -- Anxiety Disorder and Substance Use Disorder Co-Morbidity: Common Themes and Future Directions.
|
520 |
|
|
|a "It takes my worries away…it helps me unwind when I’m tense…" Those with an anxiety disorder are at two to five times greater risk of having an alcohol or drug use disorder than those without an anxiety disorder. And although anxiety disorders are among the most common co-occurring conditions affecting people with substance issues, mainstream methods often fail to treat both halves of the picture. Anxiety and Substance Use Disorders: The Vicious Cycle of Comorbidity addresses this gap with dispatches from the frontlines of research and treatment. Thirty-four international experts offer findings, theories, and intervention strategies for this common form of dual disorder both across types of substances (alcohol, tobacco, street and prescription drugs) and the range of anxiety disorders (PTSD, social phobia, panic disorder, OCD) to give the reader comprehensive knowledge in a practical format. Informed by the reciprocal relationship between the two types of disorders (such as the contributions of substance abuse to anxiety-related symptoms), the book: Brings together neurobiological, psychosocial, and cognitive perspectives on its subject. Outlines theoretical models of co-occurring anxiety and substance abuse, its epidemiology, and etiology. Offers up-to-date research findings on the nature, origins, and treatment of specific combinations of substance use and anxiety disorders. Presents detailed reviews of emerging targeted treatment methods—including cognitive-behavioral, personality-based, and medical interventions—with latest data on their efficacy. Pinpoints future directions in understanding and treating the dually diagnosed. This integrative approach makes Anxiety and Substance Use Disorders: The Vicious Cycle of Comorbidity an important resource for all mental health professionals. It will also serve as an excellent clinical text. .
|
650 |
|
0 |
|a Clinical psychology.
|
650 |
|
0 |
|a Behavioral therapy.
|
650 |
|
0 |
|a Psychotherapy.
|
650 |
|
0 |
|a Counseling.
|
650 |
1 |
4 |
|a Clinical Psychology.
|0 https://scigraph.springernature.com/ontologies/product-market-codes/Y12005
|
650 |
2 |
4 |
|a Behavioral Therapy.
|0 https://scigraph.springernature.com/ontologies/product-market-codes/H54018
|
650 |
2 |
4 |
|a Psychotherapy and Counseling.
|0 https://scigraph.springernature.com/ontologies/product-market-codes/Y12010
|
700 |
1 |
|
|a Stewart, Sherry H.
|e editor.
|4 edt
|4 http://id.loc.gov/vocabulary/relators/edt
|
700 |
1 |
|
|a Conrod, Patricia.
|e editor.
|4 edt
|4 http://id.loc.gov/vocabulary/relators/edt
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer Nature eBook
|
776 |
0 |
8 |
|i Printed edition:
|z 9781441944924
|
776 |
0 |
8 |
|i Printed edition:
|z 9780387520667
|
776 |
0 |
8 |
|i Printed edition:
|z 9780387742892
|
830 |
|
0 |
|a Series in Anxiety and Related Disorders
|
856 |
4 |
0 |
|u https://doi.org/10.1007/978-0-387-74290-8
|
912 |
|
|
|a ZDB-2-BHS
|
912 |
|
|
|a ZDB-2-SXBP
|
950 |
|
|
|a Behavioral Science (SpringerNature-11640)
|
950 |
|
|
|a Behavioral Science and Psychology (R0) (SpringerNature-43718)
|